Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (2): 279-282    DOI: 10.12891/ceog3301.2017
Case Report Previous articles | Next articles
GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports
P. Bakas1, *(), I. Boutas1, M. Giner1, P. Panagopoulos2, L. Aravantinos1
1 2nd Department of Obstetrics and Gynecology, Aretaieio Hospital, University of Athens, Athens, Greece
2 3rd Department of Obstetrics and Gynecology, Attiko Hospital, University of Athens, Athens, Greece
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To describe two clinical cases concerning patients at risk of developing severe ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) stimulation. Design: Description of clinical management and outcomes of patients using an IVF antagonist rescue protocol to prevent OHSS. Setting: Reproductive medicine unit, University Hospital. Materials and Methods: Two infertile patients undergoing controlled ovarian stimulation (COS) for IVF/intracytoplasmic sperm injection (ICSI) presenting with high risk of OHSS. IVF/ICSI patients following COS under short protocol and high risk of OHSS were managed by withdrawing the agonist and replacing it with an antagonist and triggering ovulation with an agonist bolus. Main outcome measures included incidence of OHSS, oocytes retrieved, and pregnancy rates. Results: None of the two patients developed OHSS. None of the patients had metaphase II retrieved oocytes at oocyte retrieval. Conclusions: Use of COS with short protocol in an IVF/ICSI cycle carries a risk of severe OHSS. Rescuing the cycle by withdrawing the agonist and replacing it with an antagonist and triggering ovulation with an agonist bolus is not always effective and should not be used if short time interval between agonist replacement with antagonist and ovulation triggering is available.
Key words:  GnRH antagonist      Rescue      Agonist      Agonist trigger      OHSS      IVF     
Published:  10 April 2017     
*Corresponding Author(s):  P. BAKAS     E-mail:  p_bakas@yahoo.com

Cite this article: 

P. Bakas, I. Boutas, M. Giner, P. Panagopoulos, L. Aravantinos. GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 279-282.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3301.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I2/279

[1] Pelin Kutlu, Seda Karabulut, Oya Korkmaz. Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1025-1031.
[2] Yu Deng, Zhan-Hui Ou, Min-Na Yin, Pei-Ling Liang, Zhi-Heng Chen, Abraham Morse, Ling Sun. Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 835-841.
[3] Aybike Pekin, Ayşe Gül Kebapçılar, Ersin Çintesun, Setenay Arzu Yılmaz, Özlem Seçilmiş Kerimoğlu. Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 924-928.
[4] Nur Dokuzeylul Gungor, Kagan Güngör, Mustecep Kavrut, Arzu Yurci. A retrospective series of homologous intracytoplasmic sperm injection cycle results of 99 women with mosaic Turner syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 942-948.
[5] Engin Turkgeldi, Sule Yildiz, Berk Angun, Bulent Urman, Baris Ata. Oocyte yield of GnRH antagonist cycles scheduled with a short course of estradiol in the early follicular phase[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 278-282.
[6] Guy Shrem, Nouf M. Alasmari, Jacques Balayla, Alexander Volodarsky-Perel, Weon-Young Son, Michael H. Dahan. Paternal age predicts live birth in women above 40 years of age undergoing in-vitro fertilization (IVF)[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 299-306.
[7] R. Duraker, E.S. Guvendag Guven, S. Dilbaz, A. Mentese, S. Aydın, S. Guven. Oxidative stress status in severe OHSS patients who underwent long agonist protocol intracytoplasmic sperm injection cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 312-316.
[8] Z. Merhi, J. Zhang. At-Home IVF Kit: application during the COVID-19 pandemic[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 653-659.
[9] C. Chan, J.W. Wang, C.W. Wang, C.W. Chang. A pitfall in ultrasonographic diagnosis–heterotopic cornual pregnancy initially misdiagnosed as leiomyoma[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 296-298.
[10] M.S. Jo, H.J. Lee, Y.J. Lee, S.C. Kim, J.K. Joo, K.S. Lee. Which is the safer method for trophectoderm biopsy in mouse blastocyst, mechanical or laser?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 27-30.
[11] P. Bakas, M. Simopoulou, P. Panagopoulos, N. Salakos, Ch. Siristatidis. Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 727-730.
[12] J.H. Check, M.P. Dougherty. Injection of human chorionic gonadotropin (hCG) can cause the luteinized unruptured follicle syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 635-636.
[13] H. Kwon, J.E. Shin, H. Kim. A novel treatment of severe dysmenorrhea due to adenomyosis: a case series of 3 infertile patients treated with dopamine agonist and in vitro fertilization-embryo transfer resulting in successful pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 637-640.
[14] D. Summers, J.H. Check, R. Cohen, J.K. Choe. A live normal baby is possible despite exposure of a cleaving embryo in culture to extensive smoke and heat from a raging fire and exposure to chemicals used to extinguishing the fire[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 646-647.
[15] M. Novakovic, S.V. Jankovic, I. Stojic, J. Djuric, M. Folic, N. Folic, A. Dimitrijevic, G. Babic, D. Stojadinovic, S.M. Jankovic. Effects of selective agonists of adenosine, P2X, and P2Y receptors on motility of isolated fallopian tube[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 394-397.
No Suggested Reading articles found!